Explore
Validate
Learn13163-1-AP
antibody from Proteintech Group
Targeting: FOLH1
FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [18]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13163-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13163-1-AP, RRID:AB_2106442
- Product name
- PSMA/GCPII antibody
- Antibody type
- Polyclonal
- Description
- PSMA/GCPII antibody (Cat. #13163-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Autocatalytic Signal Amplification via Orthogonal Recognition of Dual Proteins on the Surface of Serum Extracellular Vesicles for Precise Diagnosis of Prostate Cancer.
Enhanced NIR-II Nanoparticle Probe for PSMA-Targeted Molecular Imaging and Prostate Cancer Diagnosis.
Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis.
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.
Dual targeting PET tracer [(68)Ga]Ga-PSFA-01 in patients with prostate cancers: A pilot exploratory study.
Novel tetravalent bispecific antibody, PSMA/TRAIL‑R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity.
BOOST: a robust ten-fold expansion method on hour-scale.
PSMA-Targeting Imprinted Nanogels for Prostate Tumor Localization and Imaging.
Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy.
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.
EANM'23 Abstract Book Congress Sep 9-13, 2023.
European journal of nuclear medicine and molecular imaging 2023 Sep;50(Suppl 1):1-898
Increasing Aspartoacylase in the Central Amygdala: The Common Mechanism of Gastroprotective Effects of Monoamine-Based Antidepressants Against Stress.
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.
Autoradiography on deparaffinized tissue sections - A feasibility study with (68)Ga-labeled PET-tracers.
Rolling Circle Amplification-Assisted Flow Cytometry Approach for Simultaneous Profiling of Exosomal Surface Proteins.
PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Tao J, Yang L, Chen J, Yue S, Song C, Liang C, Zhou J, Wang H
ACS sensors 2026 Jan 23;11(1):181-189
ACS sensors 2026 Jan 23;11(1):181-189
Enhanced NIR-II Nanoparticle Probe for PSMA-Targeted Molecular Imaging and Prostate Cancer Diagnosis.
Jiang Z, Zhang J, Jin J, Zhang X, Kadeerhan G, Guo H, Wang D
International journal of nanomedicine 2025;20:9807-9823
International journal of nanomedicine 2025;20:9807-9823
Cellular Synthesis of Targeted Ultrasound Molecular Imaging Probe and Its Application in Prostate Cancer Diagnosis.
Li Z, Liu T, Cui T, Shen X, Liu C, Yan F
International journal of nanomedicine 2025;20:15921-15937
International journal of nanomedicine 2025;20:15921-15937
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.
Bathla S, Datta D, Bolat D, Woo E, Duque A, Arellano JI, Arnsten AFT, Nairn AC
Frontiers in aging neuroscience 2025;17:1549770
Frontiers in aging neuroscience 2025;17:1549770
Dual targeting PET tracer [(68)Ga]Ga-PSFA-01 in patients with prostate cancers: A pilot exploratory study.
Li Y, Guan L, Zhang X, Li J, Wang X, Li W, Xu L, Liu S, Tang Z, Cui M, Pang H
Theranostics 2025;15(9):4124-4134
Theranostics 2025;15(9):4124-4134
Novel tetravalent bispecific antibody, PSMA/TRAIL‑R2 REGULGENT™, induces selective tumor cell apoptosis without hepatotoxicity.
Nakayama M, Takagi-Maeda S, Machino Y, Nihira K, Inoue M, Takahashi N, Usami K
Oncology reports 2025 Nov;54(5)
Oncology reports 2025 Nov;54(5)
BOOST: a robust ten-fold expansion method on hour-scale.
Guo J, Yang H, Lu C, Cui D, Zhao M, Li C, Chen W, Yang Q, Li Z, Chen M, Zhao SC, Zhou J, He J, Jiang H
Nature communications 2025 Mar 2;16(1):2107
Nature communications 2025 Mar 2;16(1):2107
PSMA-Targeting Imprinted Nanogels for Prostate Tumor Localization and Imaging.
Zhang T, Berghaus M, Li Y, Song Q, Stollenwerk MM, Persson J, Shea KJ, Sellergren B, Lv Y
Advanced healthcare materials 2025 Jan;14(3):e2401929
Advanced healthcare materials 2025 Jan;14(3):e2401929
Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy.
Gao K, Xi W, Ni J, Jiang J, Lei Y, Li L, Chu J, Li R, An Y, Ouyang Y, Su R, Zhang R, Wu G
Biomaterials 2025 Apr;315:122894
Biomaterials 2025 Apr;315:122894
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.
Bathla S, Datta D, Bolat D, Woo E, Duque A, Arellano J, Arnsten A, Nairn AC
bioRxiv : the preprint server for biology 2024 Dec 9;
bioRxiv : the preprint server for biology 2024 Dec 9;
EANM'23 Abstract Book Congress Sep 9-13, 2023.
European journal of nuclear medicine and molecular imaging 2023 Sep;50(Suppl 1):1-898
Increasing Aspartoacylase in the Central Amygdala: The Common Mechanism of Gastroprotective Effects of Monoamine-Based Antidepressants Against Stress.
Yao K, Cao L, Ding H, Gao Y, Li T, Wang G, Zhang J
Frontiers in pharmacology 2022;13:823291
Frontiers in pharmacology 2022;13:823291
Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3.
Korsen JA, Kalidindi TM, Khitrov S, Samuels ZV, Chakraborty G, Gutierrez JA, Poirier JT, Rudin CM, Chen Y, Morris MJ, Pillarsetty N, Lewis JS
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Sep;63(9):1401-1407
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022 Sep;63(9):1401-1407
Autoradiography on deparaffinized tissue sections - A feasibility study with (68)Ga-labeled PET-tracers.
Klebermass EM, Dengler A, Weissenböck V, Ricken G, Wadsak W, Viernstein H, Hacker M, Mitterhauser M, Philippe C
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2022 Nov;189:110425
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2022 Nov;189:110425
Rolling Circle Amplification-Assisted Flow Cytometry Approach for Simultaneous Profiling of Exosomal Surface Proteins.
Gao X, Teng X, Dai Y, Li J
ACS sensors 2021 Oct 22;6(10):3611-3620
ACS sensors 2021 Oct 22;6(10):3611-3620
PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
Ni J, Miao T, Su M, Khan NU, Ju X, Chen H, Liu F, Han L
Journal of controlled release : official journal of the Controlled Release Society 2021 Jan 10;329:934-947
Journal of controlled release : official journal of the Controlled Release Society 2021 Jan 10;329:934-947
Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.
Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, Lewis MS, Chung LWK, Wang R
Scientific reports 2020 Jan 27;10(1):1216
Scientific reports 2020 Jan 27;10(1):1216
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA
European urology oncology 2019 Mar;2(2):166-173
European urology oncology 2019 Mar;2(2):166-173
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human liver tissue were subjected to SDS PAGE followed by western blot with 13163-1-AP(FOLH1 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PSMA/GCPII antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PSMA/GCPII. This antibody recognizes human, mouse, rat antigen. The PSMA/GCPII antibody has been validated for the following applications: ELISA, WB, IHC analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human prostate cancer using 13163-1-AP(FOLH1 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
